11 – 20 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
- 2012
-
Mark
GIRK2 Expression in Dopamine Neurons of the Substantia Nigra and Ventral Tegmental Area
(
- Contribution to journal › Article
- 2011
-
Mark
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
(
- Contribution to journal › Article
- 2010
-
Mark
The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Modeling pathophysiological aspects of Parkinson’s disease: Manipulating DA handling and alpha-synuclein expression in the nigrostriatal pathway using viral vectors
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion
(
- Contribution to journal › Article
- 2006
-
Mark
Neurogenesis in the adult brain from ballyhoo to sobriety
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Subthalamic nucleus lesioning inhibits expression and phosphorylation of c-Jun in nigral neurons in the rat's 6-OHDA model of Parkinson's disease
(
- Contribution to journal › Article
- 2005
-
Mark
Platelet-Derived Growth Factor (PDGF-BB) and Brain-Derived Neurotrophic Factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
(
- Contribution to journal › Article